Lecanemab for Early Alzheimer’s Disease: Long-Term Outcomes, Predictive Biomarkers and Novel Subcutaneous Administration Webcast at CTAD
Oct 25, 2023 5:25 PM EDT
Events & Presentations
Oct 25, 2023 5:25 PM EDT
Stockholder Communications
E-mail Alerts
FAQs